✦ LIBER ✦

Recombinant alpha-2B interferon treatment for childhood t-lymphoblastic disease in relapse. A pediatric oncology group phase II study

✍ Scribed by Stephen J. Lauer; Judith Ochs; Brad H. Pollock; George R. Buchanan

Book ID: 102673694
Publisher: John Wiley and Sons
Year: 1994
Tongue: English
Weight: 569 KB
Volume: 74
Category: Article
ISSN: 0008-543X
DOI: 10.1002/1097-0142(19940701)74:1<197::aid-cncr2820740131>3.0.co;2-9

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Pegylated recombinant interferon alpha-2

Pegylated recombinant interferon alpha-2b vs recombinant interferon alpha-2b for the initial treatment of chronic-phase chronic myelogenous leukemia: a phase III study

✍ Michallet, M; Maloisel, F; Delain, M; Hellmann, A; Rosas, A; Silver, R T; Tendle 📂 Article 📅 2003 🏛 Nature Publishing Group 🌐 English ⚖ 137 KB

Deoxycoformycin treatment for childhood

Deoxycoformycin treatment for childhood T-cell acute lymphoblastic leukemia early in second remission: A pediatric oncology group study

✍ Winick, Naomi ;Buchanan, George R. ;Murphy, Sharon B. ;Yu, Alice ;Boyett, James 📂 Article 📅 1988 🏛 John Wiley and Sons 🌐 English ⚖ 552 KB

2-Deoxycoformycin (DCF) was added to an intensive Pediatric Oncology Group protocol (#8303) for children with T-cell acute lymphoblastic leukemia or T-cell lymphoblastic lymphoma in first relapse. Twenty-seven patients received one or more courses of DCF at 15 mg/m2/day as a 3-day continuous infusio